STARKS DANIEL J Insider Trading Activity

Average Profitability
9.75%
Insider Buys Quantity
1
Insider Buys Sum
$7.43M
Insider Sells Quantity
6
Insider Sells Sum
$24.54M

Insider Activity of STARKS DANIEL J

According to the SEC Form 4 filings, STARKS DANIEL J, being in a position of

  1. director at Abbott Laboratories,
    оver the last 12 months, has bought 20000 shares for $2.01M, and sold 0 shares,
    over all time since 2018-02-27, has bought 142421 share for $9.45M, and sold 233872 shares for $24.54M.

Biography of STARKS DANIEL J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $2,013,8682100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-04-27PurchaseAbbott Laboratories
ABT
director
10,000
0.0006%
$92.65$926,537+9.2%
2026-02-04PurchaseAbbott Laboratories
ABT
director
10,000
0.0006%
$108.73$1.09M-4.46%
2023-10-26SaleAbbott Laboratories
ABT
director
50,000
0.0029%
$94.05$4.7M+17.47%
2023-07-27SaleAbbott Laboratories
ABT
director
50,000
0.0029%
$113.76$5.69M-5.58%
2023-05-02SaleAbbott Laboratories
ABT
director
50,000
0.0029%
$111.02$5.55M-3.08%
2022-10-27SaleAbbott Laboratories
ABT
director
50,000
0.0028%
$97.46$4.87M+9.27%
2022-07-26SaleAbbott Laboratories
ABT
27,749
0.0022%
$108.77$3.02M-1.93%
2022-05-03SaleAbbott Laboratories
ABT
6,123
0.0004%
$114.84$703,171-4.36%
2018-02-27PurchaseAbbott Laboratories
ABT
director
122,421
0.007%
$60.71$7.43M+9.73%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.